Parametric Portfolio Associates’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$2.09M Sell
55,935
-38,475
-41% -$1.48M ﹤0.01% 2405
2021
Q4
$3.76M Buy
94,410
+7,548
+9% +$289K ﹤0.01% 2057
2021
Q3
$3.23M Buy
86,862
+14,914
+21% +$613K ﹤0.01% 2130
2021
Q2
$3.04M Buy
71,948
+8,177
+13% +$350K ﹤0.01% 2179
2021
Q1
$3.02M Buy
63,771
+9,043
+17% +$537K ﹤0.01% 2520
2020
Q4
$3.34M Buy
54,728
+5,087
+10% +$300K ﹤0.01% 2341
2020
Q3
$2.32M Buy
49,641
+5,480
+12% +$270K ﹤0.01% 2413
2020
Q2
$2.24M Sell
44,161
-1,182
-3% -$58.1K ﹤0.01% 2426
2020
Q1
$2.02M Buy
45,343
+6,949
+18% +$350K ﹤0.01% 2371
2019
Q4
$1.84M Buy
38,394
+1,066
+3% +$45.3K ﹤0.01% 2742
2019
Q3
$1.26M Buy
37,328
+3,620
+11% +$158K ﹤0.01% 2905
2019
Q2
$1.52M Sell
33,708
-7,814
-19% -$309K ﹤0.01% 2830
2019
Q1
$1.56M Sell
41,522
-898
-2% -$30.1K ﹤0.01% 2793
2018
Q4
$1.46M Buy
42,420
+16,029
+61% +$576K ﹤0.01% 2784
2018
Q3
$1.24M Sell
26,391
-1,398
-5% -$57.8K ﹤0.01% 2969
2018
Q2
$937K Buy
27,789
+720
+3% +$22.5K ﹤0.01% 3091
2018
Q1
$732K Sell
27,069
-51
-0.2% -$1.29K ﹤0.01% 3168
2017
Q4
$452K Buy
27,120
+381
+1% +$6.45K ﹤0.01% 3382
2017
Q3
$535K Sell
26,739
-21,265
-44% -$416K ﹤0.01% 3385
2017
Q2
$880K Buy
48,004
+7,788
+19% +$105K ﹤0.01% 3048
2017
Q1
$396K Sell
40,216
-42,457
-51% -$514K ﹤0.01% 3315
2016
Q4
$902K Buy
82,673
+38,996
+89% +$409K ﹤0.01% 2897
2016
Q3
$612K Sell
43,677
-9,507
-18% -$77.3K ﹤0.01% 3076
2016
Q2
$373K Buy
53,184
+34,112
+179% +$250K ﹤0.01% 3351
2016
Q1
$123K Sell
19,072
-177,846
-90% -$3.09M ﹤0.01% 3835
2015
Q4
$6.38M Buy
196,918
+178,349
+960% +$5.25M 0.01% 1151
2015
Q3
$496K Buy
18,569
+3,904
+27% +$167K ﹤0.01% 2726
2015
Q2
$706K Buy
14,665
+2,226
+18% +$130K ﹤0.01% 3030
2015
Q1
$757K Buy
12,439
+579
+5% +$35.3K ﹤0.01% 2989
2014
Q4
$614K Buy
11,860
+905
+8% +$39.8K ﹤0.01% 3145
2014
Q3
$482K Buy
+10,955
New +$343K ﹤0.01% 3229

Other funds holding PTCT